Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 115 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
This article has been cited by
1The prevalence of dislipidemia and its relation to other risk factors: a nationwide survey of Lithuania
Egidija Rinkuniene,Aleksandras Laucevicius,Žaneta Petrulioniene,Vilma Dženkeviciute,Sandra Kutkiene,Agne Skujaite,Vytautas Kasiulevicius
Clinical Lipidology.2015;10(3)219
[DOI]
2Atherogenic Risk Assessment among Persons Living in Rural Uganda
Clara Wekesa,Gershim Asiki,Ivan Kasamba,Laban Waswa,Steven J. Reynolds,Rebecca N. Nsubuga,Rob Newton,Anatoli Kamali
Journal of Tropical Medicine.2016;2016(3)1
[DOI]
3Cross-sectional study of prevalence and determinants of uncontrolled hypertension among South African adult residents of Mkhondo municipality
Charity Masilela,Brendon Pearce,Joven Jebio Ongole,Oladele Vincent Adeniyi,Mongi Benjeddou
BMC Public Health.2020;20(1)1
[DOI]
4Metabolic-related markers and inflammatory factors as predictors of dyslipidemia among urban Han Chinese adults
Ying Lian,Lingling Xie,Yafei Liu,Fang Tang
Lipids in Health and Disease.2019;18(1)1
[DOI]
5Impaired fasting glucose and major adverse cardiovascular events by hypertension and dyslipidemia status: the Golestan cohort study
Nahid Hashemi Madani,Faramarz Ismail-Beigi,Hossein Poustchi,Mahdi Nalini,Sadaf G. Sepanlou,Mojtaba Malek,Mohammad Amin Abbasi,Alireza Khajavi,Mohammad E. Khamseh,Reza Malekzadeh
BMC Cardiovascular Disorders.2020;20(1)1
[DOI]
6Post Hoc Analysis of the CONFIDENCE II, PROTECT I, SHAKE THE HABIT I and SHAKE THE HABIT II Observational Studies in Mild to Moderate Hypertensive Patients Treated with Perindopril and Atorvastatin Concomitantly
John S. Sampalis,Eliofotisti Psaradellis,Melissa Stutz,Jenaya Rickard,Emmanouil Rampakakis
Drugs in R&D.2018;18(4)283
[DOI]
7Cardiovascular risk assessment of dyslipidemic middle-aged adults without overt cardiovascular disease over the period of 2009–2016 in Lithuania
Sandra Kutkiene,Zaneta Petrulioniene,Aleksandras Laucevicius,Pranas Serpytis,Vytautas Kasiulevicius,Justina Staigyte,Akvile Saulyte,Emilija Petrulionyte,Urte Gargalskaite,Egle Skiauteryte,Gabija Matuzeviciene,Milda Kovaite,Egidija Rinkuniene
Lipids in Health and Disease.2018;17(1)283
[DOI]
8Association of endothelial nitric oxide synthase (eNOS) gene G894T polymorphism with hypertension risk and complications
Abeer A. ALrefai,Mona Salah El-din Habib,Rehab I. Yaseen,Mahmoud K. Gabr,Rabab M. Habeeb
Molecular and Cellular Biochemistry.2016;421(1-2)103
[DOI]
9Incidence and risk factors for progression from prehypertension to hypertension: a 12-year Korean Cohort Study
Eun Sun Yu,Kwan Hong,Byung Chul Chun
Journal of Hypertension.2020;38(9)1755
[DOI]
10Evaluation of lipid profiles and hematological parameters in hypertensive patients: Laboratory-based cross-sectional study
Alemu Gebrie,Natesan Gnanasekaran,Menakath Menon,Mekonnen Sisay,Abriham Zegeye
SAGE Open Medicine.2018;6(9)205031211875666
[DOI]
11Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea
Jimin Lee,Sukhyang Lee
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.2018;38(11)1095
[DOI]
12Protocol for a prospective longitudinal study of risk factors for hypertension incidence in a Mexico City population: the Tlalpan 2020 cohort
Eloisa Colín-Ramírez,Susana Rivera-Mancía,Oscar Infante-Vázquez,Raúl Cartas-Rosado,Jesús Vargas-Barrón,Magdalena Madero,Maite Vallejo
BMJ Open.2017;7(7)e016773
[DOI]
13Eryptosis and oxidative damage in hypertensive and dyslipidemic patients
Carmen Elisa Pinzón-Díaz,José Víctor Calderón-Salinas,Margarita Marcela Rosas-Flores,Gerardo Hernández,Alicia López-Betancourt,Martha Angélica Quintanar-Escorza
Molecular and Cellular Biochemistry.2018;440(1-2)105
[DOI]
14Interactions of Six SNPs in ABCA1gene and Obesity in Low HDL-C Disease in Kazakh of China
Ming-hong Yao,Heng Guo,Jia He,Yi-zhong Yan,Ru-lin Ma,Yu-song Ding,Jing-yu Zhang,Jia-ming Liu,Mei Zhang,Shu-gang Li,Shang-zhi Xu,Qiang Niu,Jiao-long Ma,Shu-xia Guo
International Journal of Environmental Research and Public Health.2016;13(2)176
[DOI]
15Blood pressure control, glycemic control, and dyslipidemia among healthy adults in the Cape Coast metropolis, Ghana
Worlanyo Eric Gato,Samuel Acquah,Paul Nsiah,Samuel Tawiah Opoku,Bettye Appiah Apenteng,Benjamin Kwasi Johnson
Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2019;13(1)56
[DOI]
16Blood pressure–lowering activity of statins: a systematic literature review and meta-analysis of placebo-randomized controlled trials
Jahad Alghamdi,Abdulziz Alqadi,Adel Alharf,Bader Almuzzaini,Azra Mahmud,Tlili Barhoumi,Hisham A Badreldin,Manal Alaamery,Sandosh Padmanabhan
European Journal of Clinical Pharmacology.2020;13(1)56
[DOI]
17Glycemic effects of simvastatin: Where do we stand?
Nor Razida Razali,Hasniza Zaman Huri,Luqman Ibrahim,Shireene Ratna Vethakkan,Bashar Mudhaffar Abdullah
Brazilian Journal of Pharmaceutical Sciences.2018;54(1)56
[DOI]
18Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy
Xiaowei Yan,Yong Li,Yugang Dong,Yanhua Wu,Jihu Li,Rui Bian,Dayi Hu
Lipids in Health and Disease.2019;18(1)56
[DOI]
19Association of Vascular Risk Factors With ß-Amyloid Peptide and Tau Burdens in Cognitively Unimpaired Individuals and Its Interaction With Vascular Medication Use
Theresa Köbe,Julie Gonneaud,Alexa Pichet Binette,Pierre-François Meyer,Melissa McSweeney,Pedro Rosa-Neto,John C. S. Breitner,Judes Poirier,Sylvia Villeneuve
JAMA Network Open.2020;3(2)e1920780
[DOI]
20Metabolomic characterization of hypertension and dyslipidemia
Chaofu Ke,Xiaohong Zhu,Yuxia Zhang,Yueping Shen
Metabolomics.2018;14(9)e1920780
[DOI]
21Hypocholesterolemia is an independent risk factor for depression disorder and suicide attempt in Northern Mexican population
Marcela Segoviano-Mendoza,Manuel Cárdenas-de la Cruz,José Salas-Pacheco,Fernando Vázquez-Alaniz,Osmel La Llave-León,Francisco Castellanos-Juárez,Jazmín Méndez-Hernández,Marcelo Barraza-Salas,Ernesto Miranda-Morales,Oscar Arias-Carrión,Edna Méndez-Hernández
BMC Psychiatry.2018;18(1)e1920780
[DOI]
22Indicators of accumulated fat are stronger associated with prehypertension compared with indicators of circulating fat
Susana Rivera-Mancía,Eloisa Colín-Ramírez,Raúl Cartas-Rosado,Oscar Infante,Jesús Vargas-Barrón,Maite Vallejo
Medicine.2018;97(34)e11869
[DOI]
23Indicators of accumulated fat are stronger associated with prehypertension compared with indicators of circulating fat
Neel Shimpi,Ram Pathak,Amit Acharya
Medicine.2019;97(34)141
[DOI]
24Dyslipidemia Associated with Hypertension Increases the Risks for Coronary Heart Disease: A Case-Control Study in Harapan Kita Hospital, National Cardiovascular Center, Jakarta
Rea Ariyanti,Besral Besral
Journal of Lipids.2019;2019(34)1
[DOI]
  Feedback 
  Subscribe 

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal